Generics 675

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cefixime manufacturers

675 products found

Filters

675 products found

cefixime

Tablets 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

cefixime

Tablets, film coated 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP submitted 07/2023, RMS: CY
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

cefixime

Syrup 100 mg/5 ml - 50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16182
It is a family-owned company based in Western Europe that specializes in the production of pediatric pharmaceuticals. All of the medicines give the added value that patients, physicians, and pharmacists have grown to expect from the company over the past 30 years as a top pediatric pharmaceutical company in the country. More than 130 products are available in the portfolio for a wide range of indications in dermatology, allergology, respiratory disorders, and ENT.

Manufacturer usually replies in 7 days

cefixime

Tablets 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal
Manufacturer #20828
It is a pharmaceutical firm dedicated to improving the health and quality of human life. And what the corporation can manufacture and refine to match consumer demands. The company was established in the 1980s. Since then it has been in business for 25 years.

Manufacturer usually replies in 7 days

cefixime

Tablets, film coated 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Vietnam , United States
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefixime

Tablets, orally disintegrating (ODT) 400mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefixime

Oral suspension 100 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Iran , Iraq , United States , Vietnam , Kosovo
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefixime

Capsules 400mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefixime

Capsules 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Reference product: Oroken, Aventis, Cefixoral 400 mg Menari
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

cefixime

Capsules 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Dossier availability depending on country legislation
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

cefixime

Capsules 400 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
File status: Q4 2023
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

cefixime

Oral suspension 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

cefixime

Capsules 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

cefixime

Capsules 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #21307

Manufacturer usually replies in 2 days

cefixime

Granules for oral suspension 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

cefixime

Capsules 200 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

cefixime

Granules for oral suspension 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

cefixime

Oral suspension 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

cefixime

Capsules 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

cefixime

Capsules 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17805

Manufacturer usually replies in 2 days

Want to view all 675 products? Create your free account today!

Cefixime Manufacturers

Cefixime is an antibiotic used to treat a wide range of bacterial infections, including but not limited to strep throat, otitis media, urinary tract infections, pneumonia, gonorrhea. Although manufacturers of cefixime produce drugs with it as the standalone ingredient, it is also used in combination formulations along with other active substances such as ofloxacin, clavulanic acid, and ornidazole. Cefixime suppliers market it in the form of oral capsules and tablets as well as oral suspensions. First approved in 1989, cefixime has since become included in the World Health Organization’s List of Essential Medicines that contain the most important medications recommended for a basic health system. It is one of the more popular cephalosporin class drugs, and, as such, has many substitutes that belong to this class of medications. Few of them, however, have merited inclusion into the WHO’s list, which attests to cefixime's creditable safety and efficacy profiles. The global market for the drug is relatively fragmented, with multiple pharmaceutical producers and suppliers distributing their cefixime formulations. Among the largest manufacturers of cefixime are companies ACS Dobfar, Covalent Laboratories, Luoxin Pharmaceutical, Nishchem International, Dhanuka Laboratories, Reva Pharma, and Orchid Pharma. Cefixime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug (for example, counterfeit cefixime products are commonly marketed in India under the trade name Zifi 200), whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefixime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. A mixture of cefixime, azithromycin, vitamin D, vitamin C, and zinc may be effective in treating mild COVID-19 symptoms. Cefixime and amoxicillin had comparable clinical and bacteriologic effectiveness for otitis media. Cefixime was more effective than amoxicillin in treating H. influenzae otitis media and should be used when this pathogen is suspected. Ideally, cefixime or ceftriaxone would be used in women with PID and no BV present, but cefoxitin would be preferred due to its higher anaerobic coverage in the presence of PID and concurrent BV.

How does Cefixime work?

Cefixime is being used to kill bacteria throughout the system. It refers to the cephalosporin antibiotics type of medication. It acts by either killing or inhibiting the growth of bacteria. This medication, however, will not treat common cold, flu, or even other virus infections. Cefixime takes 7 to 14 days to be effective for treating gonorrhoea. Other problems may differ depending on the person and their sensitivity for the drug. It is usually taken once or twice per day. One pill per day is sufficient for gonorrhoea.

The Cost of Cefixime

An online search for the wholesale price for sale of Cefixime for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Cefixime distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Cefixime suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Cefixime. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Cefixime is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Cefixime suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Cefixime for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.